California's Youth Smoking and Vaping Rates Decrease in 2021

Oct.18.2022
California's Youth Smoking and Vaping Rates Decrease in 2021
The CHKS report shows a decline in tobacco and e-cigarette use among California students, attributed to T21 law.

According to a report from the California Healthy Kids Survey (CHKS), only 1% of 7th and 9th-grade students, and 2% of 11th-grade students reported smoking in 2021, defined as smoking "one or more days" within 30 days prior to the survey. The data also shows that since 2015, smoking rates have decreased by 50% among 7th-grade students, 75% among 9th-grade students, and 71.4% among 11th-grade students.


Furthermore, the use of e-cigarettes has also dropped. According to a survey, e-cigarette usage peaked in 2015, with 7% of students, 13% of 9th graders, and 14% of 11th graders reporting they had used e-cigarettes in the 30 days prior to the survey. However, in 2021, this rate hit an all-time low, with only 2% of 7th graders, 6% of 9th graders, and 10% of 11th graders reporting current e-cigarette use.


Earlier this year, additional data was released regarding the legal impact of California in 2016, which reported a positive trend. The law raised the legal age for tobacco sales from 18 to 21 (T21). In 2016, California passed a law that raised the age limit for tobacco sales from 18 to 21. The Pacific Research and Evaluation Prevention Research Center conducted a study called "New research investigating the impact of California's minimum age of 21 for tobacco sales.


Data compilation shows that the T21 law has had a positive impact on public health among 7th, 9th, and 11th grade students statewide. The survey results are summarized on News-Medical.


Reduce the prevalence of lifelong use of combustible tobacco and e-cigarettes, as well as the past month's use of combustible tobacco among the entire student population.


Over the past month, there has been an increase in the usage of electronic cigarettes.


Reduce lifetime and past 30-day use of all tobacco and nicotine products among Latinx youth.


Positive public health impacts on other racial and ethnic groups that are distinct.


Title: California's E-cigarette Usage Rates, T21, California Health Children Survey A recent survey in California has revealed significant statistics on the usage of electronic cigarettes, also known as e-cigarettes, in the state. The survey also examined the T21, a law that raises the minimum age for buying tobacco products, including e-cigarettes, to 21. The survey, named California Health Children Survey, reported that 7% of surveyed high school students had used e-cigarettes at least once in the past 30 days. Moreover, 15% of 11th graders reported current usage of e-cigarettes. The survey also showed that T21 has resulted in a decrease in tobacco product usage among youths under 21 years old. There has been a significant drop in the usage of e-cigarettes, with a decrease of 6% in the past 12 months alone. Overall, the survey suggests that e-cigarette usage remains an issue in California, particularly among high school students. However, the implementation of T21 has shown a positive impact in decreasing tobacco usage among younger demographics, including e-cigarettes.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its contents. The translation of this article is intended only for industry exchange and research purposes.


Due to limitations in the level of translation, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
Dragos Constantinescu has officially taken up his role as Chief Financial Officer and Executive Director at British American Tobacco (BAT). He previously spent 16 years at BAT across finance and general management roles in Europe before joining Asahi in 2019 and becoming CEO of Asahi Europe & International in 2025. His return comes as BAT continues to advance its “A Better Tomorrow” transformation.
BAT
Sep.01
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22